Results
9
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
9 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MAGLE | SEK 39.00 | -1.0% | 22.6% | SEK 421.2m | SEK 50.00 | PE54.7x | E72.2% | n/a | ||
BIOA B | SEK 162.50 | -4.0% | -41.6% | SEK 14.4b | SEK 290.60 | PS48x | E98.4% | 0% | ||
BIOVIC B | SEK 2.65 | -7.0% | -66.9% | SEK 239.0m | SEK 6.20 | PS33x | E78.5% | n/a | ||
SENZA | SEK 7.00 | -6.0% | -14.4% | SEK 206.5m | SEK 16.00 | PS3.7x | E109.9% | n/a | ||
KLAR | SEK 0.77 | 5.5% | 39.3% | SEK 99.4m | SEK 1.00 | PB4.8x | E57.8% | n/a | ||
EGTX | SEK 4.51 | -5.7% | 2.9% | SEK 1.3b | SEK 11.40 | PS18.6x | E90.0% | n/a | ||
ORX | SEK 14.14 | -5.5% | -16.0% | SEK 487.9m | SEK 21.50 | PB20.2x | E74.3% | n/a | ||
GENO | SEK 23.20 | 2.2% | -47.6% | SEK 1.5b | SEK 43.00 | PE88.1x | E28.8% | n/a | ||
SECARE | SEK 43.72 | -2.1% | -2.9% | SEK 6.9b | SEK 63.00 | PE91.3x | E56.1% | 0.5% |